Get started
Author

Dessislava Vanosmael

ORCID: 0009-0009-6188-3250
Observed ORCID: 0009-0009-6188-3250
OpenAlex ID: A5116005922
First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al. · Clinical Cancer Research · 28
PDF
Supplementary Table 3 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Methods 1 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 6 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 4 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 1 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 3 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 2 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 1 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 2 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 5 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 4 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 5 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 6 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 7 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 2 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 1 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 3 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 7 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Table 4 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Data from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 3 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 1 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 4 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Supplementary Figure 5 from First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors
2025 · Anthony El-Khoueiry, Omar Saavedra, et al.
Works count: 30
Citation count: 28
H-index: 1
I10-index: 1
Year
Topic
Type